CorMedix
CRMD
#7304
Rank
A$0.82 B
Marketcap
A$10.57
Share price
0.82%
Change (1 day)
-35.08%
Change (1 year)

Earnings for CorMedix (CRMD)

Earnings in 2026 (TTM): A$0.30 Billion

According to CorMedix's latest financial reports the company's current earnings are A$0.45 Billion. In 2025 the company made an earning of A$0.21 Billion, an increase over its 2024 earnings that were of -A$27.68 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CorMedix from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.30 B39.75%
2025 A$0.21 B-876.29%
2024 -A$27.68 Million-58.3%
2023 -A$66.37 Million53%
2022 -A$43.38 Million2.81%
2021 -A$42.2 Million8.32%
2020 -A$38.95 Million26.53%
2019 -A$30.79 Million-19.89%
2018 -A$38.43 Million-18.72%
2017 -A$47.28 Million34.56%
2016 -A$35.14 Million34.88%
2015 -A$26.05 Million-11.08%
2014 -A$29.3 Million124.69%
2013 -A$13.04 Million144.91%
2012 -A$5.33 Million-48.41%
2011 -A$10.32 Million-33.29%
2010 -A$15.47 Million78.42%
2009 -A$8.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Becton Dickinson
BDX
A$2.14 B 635.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$18.44 M-93.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-A$0.14 Billion-146.75%๐Ÿ‡บ๐Ÿ‡ธ USA